Consistently, NF-κB inhibition has repeatedly been used as an approach to radiosensitise tumour cells by stimulating apoptosis or by inhibiting DNA repair (Wang et al, 1996; Miyakoshi and Yagi, 2000; Russo et al, 2001). This evidence concerns the gene NFKB1 and neoplasm.